LL-TCK 5'-UTR DNA Sequence Enhances Plant Protein Expression

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current leader sequences in plant expression vectors, such as the 5'-UTR in pBI121 and TMV leader Ω, are inefficient in maximizing gene expression levels of heterologous proteins, leading to production constraints that hinder industrial applications in biotechnology.

Innovation Solution

An artificial DNA sequence, LL-TCK, is designed to enhance gene expression by combining repeated trinucleotide elements CAA with dinucleotide elements CT, a poly(CAA) region, a poly(CT) region, and the octamer ACAATTAC, optimized for efficient mRNA capping and translation initiation, promoting higher expression levels of heterologous proteins in plants.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If traditional leader sequences (pBI121 5'-UTR, TMV leader Ω) are used in plant expression vectors, then the vectors are widely diffused and easy to use, but the gene expression levels of heterologous proteins are insufficient and production constraints exist

Engineering Contradiction:
Improvegene expression levelVSAvoidvector usability
Core Design Contradiction:
ProductivityVSEase of manufacture

Solution Approach 1:

The patent modifies the leader sequence by changing specific nucleotide parameters - replacing the traditional TMV leader Ω sequence with a customized sequence containing specific motifs (CACGTG, CAA repeats, CT-rich regions) and adjusting the length and composition to optimize gene expression while maintaining vector functionality

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates a composite leader sequence that integrates multiple functional elements: the CACGTG motif for transcription initiation, CAA repeat regions for translational enhancement, and CT-rich sequences for structural stability, combining these components into a single optimized 5'-UTR that achieves superior expression

Inventive Principle:
Principle #40Composite materials

2Productivity

If the TMV leader Ω sequence is used to enhance expression, then translation levels increase, but the sequence contains imperfections and redundancies that limit further improvement

Engineering Contradiction:
Improvetranslation levelVSAvoidsequence efficiency
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent extracts and isolates specific functional motifs from the TMV leader Ω sequence (such as the CAA repeat region and CT-rich sequences) and separates them from the less effective portions, creating a streamlined leader sequence that retains only the essential elements for high-level translation while eliminating redundancies

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent applies different sequence characteristics to different regions of the leader - using CACGTG at the 5' end for transcriptional activation, CAA repeats in the middle for translational enhancement, and CT-rich sequences toward the 3' end for structural optimization, with each region tailored to its specific functional requirement

Inventive Principle:
Principle #3Local quality

3Productivity

If leader sequences are extended beyond 40 nucleotides to promote authentic AUG recognition, then translation efficiency increases, but the sequence length and complexity increase

Engineering Contradiction:
Improvetranslation efficiencyVSAvoidleader sequence length
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent extends the leader sequence beyond the minimum 40 nucleotides to an optimized length of 50-100 nucleotides, incorporating additional functional motifs that provide incremental benefits for translation efficiency and mRNA stability, accepting the increased length as necessary for achieving high-level expression

Inventive Principle:
Principle #16Partial or excessive action

Data Source

PatentEP2118291B1Artificial DNA sequence with optimized leader function in 5' (5'-UTR) for the improved expression of heterologous proteins in plants
Publication Date: 2015.06.03 RODINA HLDG
  • EP2118291B1 patent drawingFigure 1~3
  • EP2118291B1 patent drawingFigure 4a~5
  • EP2118291B1 patent drawing

AI summary

A nucleotide leader sequence 5'-UTR comprises elements favorable to gene expression, such as repeated CAA trinucleotide elements in combination with repeated CT dinucleotide elements.